XML 22 R11.htm IDEA: XBRL DOCUMENT v3.7.0.1
Stock-Based Compensation Expense
6 Months Ended
Jun. 30, 2017
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]  
Stock-Based Compensation Expense
Stock-Based Compensation Expense
 
(a)
General
Stock-based compensation expense for restricted stock, restricted stock units, stock options and issuances of common stock pursuant to our employee stock purchase plan was classified in the accompanying consolidated statements of operations as follows:
 
 
Three Months Ended June 30,
 
Six Months Ended June 30,
 
 
2017
 
2016
 
2017
 
2016
 
 
(in thousands)
Stock-based compensation expense:
 
 
 
 
 
 
 
 
Cost of revenue
 
$
308

 
$
142

 
$
510

 
$
279

Research and development
 
1,689

 
1,524

 
3,202

 
3,017

Sales and marketing
 
1,779

 
1,224

 
3,182

 
4,125

General and administrative
 
1,395

 
751

 
2,556

 
1,739

Total stock-based compensation expense
 
$
5,171

 
$
3,641

 
$
9,450

 
$
9,160


We recognize compensation cost of all awards on a straight-line basis over the applicable vesting period, which is generally four years.
(b)
Restricted Stock and Restricted Stock Units
Restricted stock and restricted stock unit activity during the six months ended June 30, 2017 was as follows:
 
 
 
Restricted Stock
 
Restricted Stock Units
 
 
Shares
 
Weighted-Average
Grant Date
Fair Value
 
Shares
 
Weighted-Average
Grant Date
Fair Value
Unvested balance as of December 31, 2016
 
585,004

 
$
18.05

 
734,577

 
$
13.47

Granted
 

 

 
1,423,010

 
14.11

Vested
 
(156,765
)
 
19.04

 
(200,416
)
 
13.72

Forfeited
 
(7,698
)
 
23.01

 
(78,441
)
 
13.62

Unvested balance as of June 30, 2017
 
420,541

 
$
17.59

 
1,878,730

 
$
13.92


As of June 30, 2017, the unrecognized compensation expense related to our unvested restricted stock and restricted stock units expected to vest was $30.6 million. This unrecognized compensation expense will be recognized over an estimated weighted-average amortization period of 3.0 years.
During the six months ended June 30, 2017, we repurchased 9,534 shares of our common stock in settlement of employee tax withholding obligations due upon the vesting of restricted stock.
(c)
Stock Options
Stock option activity during the six months ended June 30, 2017 was as follows:
 
 
Shares
 
Weighted
Average
Exercise
Price
 
Weighted
Average
Remaining
Contractual Life
(in years)
 
Aggregate
Intrinsic
Value
(in thousands)
Outstanding as of December 31, 2016
 
4,580,375

 
$
8.20

 
 
 
 
Granted
 
1,266,238

 
13.38

 
 
 
 
Exercised
 
(670,533
)
 
6.13

 
 
 
$
7,572

Forfeited/cancelled
 
(134,812
)
 
12.41

 
 
 
 
Outstanding as of June 30, 2017
 
5,041,268

 
$
9.66

 
7.5
 
$
36,564

Vested and exercisable as of June 30, 2017
 
2,642,121

 
$
6.57

 
6.0
 
$
27,278

Vested and expected to vest as of June 30, 2017
 
4,544,979

 
$
9.27

 
7.1
 
$
34,726


As of June 30, 2017, the unrecognized compensation expense related to our unvested stock options expected to vest was $14.1 million. This unrecognized compensation expense will be recognized over an estimated weighted-average amortization period of 2.9 years.
The total fair value of stock options vested in the six months ended June 30, 2017 was $3.2 million. The weighted-average grant date fair value of stock options granted in the six months ended June 30, 2017 was $6.65 per share.

(d)
Employee Stock Purchase Plan
Under the Rapid7, Inc. 2015 Employee Stock Purchase Plan (ESPP), employees may set aside up to 15% of their gross earnings, on an after-tax basis, to purchase our common shares at a discounted price, which is calculated at 85% of the lesser of: (i) the market value of our common stock at the beginning of each offering period and (ii) the market value of our common stock on the applicable purchase date.
On March 15, 2017, we issued 138,085 shares of common stock to employees for aggregate proceeds of $1.5 million. The purchase prices of the shares of common stock were $10.60 and $12.79 per share, which were discounted in accordance with the terms of the ESPP from the closing prices of our common stock on March 16, 2016 of $12.47 and on March 15, 2017 of $15.05, respectively.